BioRestorative Therapies, Inc. (BRTX)
0.146
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.14
-0.01
(-4.11%)
After-Hours: 20:00
BioRestorative Therapies Cash from Investing (Quarterly) : 0.9684M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.9684M |
| December 31, 2025 | 2.401M |
| September 30, 2025 | 1.998M |
| June 30, 2025 | 2.132M |
| March 31, 2025 | 2.367M |
| December 31, 2024 | 1.533M |
| September 30, 2024 | 0.9368M |
| June 30, 2024 | 2.973M |
| March 31, 2024 | -4.928M |
| December 31, 2023 | -0.0848M |
| September 30, 2023 | -0.0214M |
| June 30, 2023 | 0.819M |
| March 31, 2023 | 2.539M |
| December 31, 2022 | -3.323M |
| September 30, 2022 | -9.909M |
| June 30, 2022 | -0.1377M |
| March 31, 2022 | -0.1096M |
| December 31, 2021 | -0.0307M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0063M |
| June 30, 2019 | -0.0294M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0129M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.0036M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.0068M |
| September 30, 2016 | -0.0307M |
| June 30, 2016 | -0.0613M |
| March 31, 2016 | -0.0899M |
| December 31, 2015 | -0.0476M |
| September 30, 2015 | -0.2086M |
| June 30, 2015 | -0.0597M |
| March 31, 2015 | -0.1672M |
| December 31, 2014 | -0.1668M |
| September 30, 2014 | -0.0015M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.001M |
| December 31, 2013 | -0.0112M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -3.20M |
| CareDx, Inc. | 280.59M |
| Natera, Inc. | -63.43M |
| Exagen, Inc. | -0.543M |
| Sera Prognostics, Inc. | 6.394M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.808M |
| Cash from Financing (Quarterly) | 4.441M |
| Free Cash Flow | -11.90M |
| Free Cash Flow Per Share (Quarterly) | -0.2148 |
| Free Cash Flow to Equity (Quarterly) | -3.699M |
| Free Cash Flow to Firm (Quarterly) | -3.808M |
| Free Cash Flow Yield | -733.2% |